Publication List 1997

1984-94, 1995, 1996, 1997, 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022

Okochi H, Kato M, Nashiro K, Yoshie O, Miyazono K, Furue M.
Expression of tetra-spans transmembrane family (CD9, CD37, CD53, CD63, CD81 and CD82) in normal and neoplastic human keratinocytes: an association of CD9 with α3β1 integrin.
Br J Dermatol. 1997 Dec;137(6):856-63.
Heldin CH, Miyazono K, ten Dijke P.
TGF-β signalling from cell membrane to nucleus through SMAD proteins.
Nature. 1997 Dec 4;390(6659):465-71.
Nakaoka T, Gonda K, Ogita T, Otawara-Hamamoto Y, Okabe F, Kira Y, Harii K, Miyazono K, Takuwa Y, Fujita T.
Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2.
J Clin Invest. 1997 Dec 1;100(11):2824-32.
Tobiume K, Inage T, Takeda K, Enomoto S, Miyazono K, Ichijo H.
Molecular cloning and characterization of the mouse apoptosis signal-regulating kinase 1.
Biochem Biophys Res Commun. 1997 Oct 29;239(3):905-10.
Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, Miyazono K.
Smad6 inhibits signalling by the TGF-β superfamily.
Nature. 1997 Oct 9;389(6651):622-6.
Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K, ten Dijke P.
TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4.
EMBO J. 1997 Sep 1;16(17):5353-62.
Yamashita H, Shimizu A, Kato M, Nishitoh H, Ichijo H, Hanyu A, Morita I, Kimura M, Makishima F, Miyazono K.
Growth/differentiation factor-5 induces angiogenesis in vivo.
Exp Cell Res. 1997 Aug 25;235(1):218-26.
Persson U, Souchelnytskyi S, Franzén P, Miyazono K, ten Dijke P, Heldin CH.
Transforming growth factor (TGF-β)-specific signaling by chimeric TGF-β type II receptor with intracellular domain of activin type IIB receptor.
J Biol Chem. 1997 Aug 22;272(34):21187-94.
Saeki K, Yuo A, Kato M, Miyazono K, Yazaki Y, Takaku F.
Cell density-dependent apoptosis in HL-60 cells, which is mediated by an unknown soluble factor, is inhibited by transforming growth factor β1 and overexpression of Bcl-2.
J Biol Chem. 1997 Aug 8;272(32):20003-10.
Beppu H, Minowa O, Miyazono K, Kawabata M.
cDNA cloning and genomic organization of the mouse BMP type II receptor.
Biochem Biophys Res Commun. 1997 Jun 27;235(3):499-504.
Olofsson A, Hellman U, Ten Dijke P, Grimsby S, Ichijo H, Morén A, Miyazono K, Heldin CH.
Latent transforming growth factor-β complex in Chinese hamster ovary cells contains the multifunctional cysteine-rich fibroblast growth factor receptor, also termed E-selectin-ligand or MG-160.
Biochem J. 1997 Jun 1;324 ( Pt 2):427-34.
Furue M, Kato M, Nakamura K, Nashiro K, Kikuchi K, Okochi H, Miyazono K, Tamaki K.
Dysregulated expression of transforming growth factor β and its type-I and type-II receptors in basal-cell carcinoma.
Int J Cancer. 1997 May 16;71(4):505-9.
Yonemori K, Imamura T, Ishidou Y, Okano T, Matsunaga S, Yoshida H, Kato M, Sampath TK, Miyazono K, ten Dijke P, Sakou T.
Bone morphogenetic protein receptors and activin receptors are highly expressed in ossified ligament tissues of patients with ossification of the posterior longitudinal ligament.
Am J Pathol. 1997 Apr;150(4):1335-47.
Miyazono K.
TGF-β receptors and signal transduction.
Int J Hematol. 1997 Feb;65(2):97-104.
Nakajima Y, Miyazono K, Kato M, Takase M, Yamagishi T, Nakamura H.
Extracellular fibrillar structure of latent TGFβ binding protein-1: role in TGFβ-dependent endothelial-mesenchymal transformation during endocardial cushion tissue formation in mouse embryonic heart.
J Cell Biol. 1997 Jan 13;136(1):193-204.
Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y.
Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways.
Science. 1997 Jan 3;275(5296):90-4.